Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Vigil Neuroscience Q3 EPS $(0.53) Beats $(0.57) Estimate; Cash Position Of $133.6M Expected To Fund Its Operational Plans Into The First Quarter Of 2025

Author: Benzinga Newsdesk | November 07, 2023 08:28am
Vigil Neuroscience (NASDAQ:VIGL) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.57) by 7.02 percent. This is unchanged from the same period last year.

Posted In: VIGL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist